Inventiva Financials

Trends View

Profitability View

Liquidity View

Fundamentals View

Competition View

Inventiva Stock Summary

Inventiva competes with Mineralys Therapeutics,, Eliem Therapeutics, Anebulo Pharmaceuticals, Janux Therapeutics, and Rezolute. Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis , mucopolysaccharidoses , and other diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. Inventiva is traded on NASDAQ Exchange in the United States.

Inventiva Key Financial Ratios

Inventiva Key Balance Sheet Accounts

Inventiva Key Income Statement Accounts

Inventiva Key Cash Accounts

Inventiva Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Inventiva's current stock value. Our valuation model uses many indicators to compare Inventiva value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inventiva competition to find correlations between indicators driving Inventiva's intrinsic value. More Info.Inventiva Sa is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Inventiva's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inventiva's earnings, one of the primary drivers of an investment's value.

Inventiva Sa Systematic Risk

Today, most investors in Inventiva Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Inventiva's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Inventiva growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Inventiva help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Inventiva Sa. We use our internally-developed statistical techniques to arrive at the intrinsic value of Inventiva Sa based on widely used predictive technical indicators. In general, we focus on analyzing Inventiva Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Inventiva's daily price indicators and compare them against related drivers.

When running Inventiva's price analysis, check to measure Inventiva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inventiva is operating at the current time. Most of Inventiva's value examination focuses on studying past and present price action to predict the probability of Inventiva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inventiva's price. Additionally, you may evaluate how the addition of Inventiva to your portfolios can decrease your overall portfolio volatility.